Gut microbiota induced epigenetic modifications in the non‐alcoholic fatty liver disease pathogenesis
Abstract: Non‐alcoholic fatty liver disease (NAFLD) represents a growing global health concern that can lead to liver disease and cancer. It is characterized by an excessive accumulation of fat in the liver, unrelated to excessive alcohol consumption. Studies indicate that the gut microbiota‐host crosstalk may play a causal role in NAFLD pathogenesis, with epigenetic modification serving as a key mechanism for regulating this interaction. In this review, we explore how the interplay between gut microbiota and the host epigenome impacts the development of NAFLD. Specifically, we discuss how gut microbiota‐derived factors, such as lipopolysaccharides (LPS) and short‐chain fatty acids (SCFAs), can modulate the DNA methylation and histone acetylation of genes associated with NAFLD, subsequently affecting lipid metabolism and immune homeostasis. Although the current literature suggests a link between gut microbiota and NAFLD development, our understanding of the molecular mechanisms and signaling pathways underlying this crosstalk remains limited. Therefore, more comprehensive epigenomic and multi‐omic studies, including broader clinical and animal experiments, are needed to further explore the mechanisms linking the gut microbiota to NAFLD‐associated genes. These studies are anticipated to improve microbial markers based on epigenetic strategies and provide novel insights into the pathogenesis of NAFLD, ultimately addressing a significant unmet clinical need.
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Gut microbiota induced epigenetic modifications in the non‐alcoholic fatty liver disease pathogenesis ; day:02 ; month:06 ; year:2023 ; extent:14
Engineering in life sciences ; (02.06.2023) (gesamt 14)
- Creator
-
Tang, Ruiqi
Liu, Rongrong
Zha, Hua
Cheng, Yiwen
Ling, Zongxin
Li, Lanjuan
- DOI
-
10.1002/elsc.202300016
- URN
-
urn:nbn:de:101:1-2023060315111012904741
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:47 AM CEST
Data provider
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Tang, Ruiqi
- Liu, Rongrong
- Zha, Hua
- Cheng, Yiwen
- Ling, Zongxin
- Li, Lanjuan
Other Objects (12)
Epigenetic Markers and Microbiota/Metabolite-Induced Epigenetic Modifications in the Pathogenesis of Obesity, Metabolic Syndrome, Type 2 Diabetes, and Non-alcoholic Fatty Liver Disease
Epigenetic modifications in lymphoma: Relevance for pathogenesis and treatment
Bioprotective Role of Phytocompounds Against the Pathogenesis of Non-alcoholic Fatty Liver Disease to Non-alcoholic Steatohepatitis: Unravelling Underlying Molecular Mechanisms
Multiple organs involved in the pathogenesis of non-alcoholic fatty liver disease
The role of epigenetic modifications for the pathogenesis of Crohn's disease
Analysis of non-alcoholic beverages
Non-alcoholic fatty liver disease
Alcoholic and non-alcoholic steatohepatitis: global perspective and emerging science
The role of hepatic fat accumulation in pathogenesis of non-alcoholic fatty liver disease (NAFLD)
The influence of mTOR inhibition on the pathogenesis of non-alcoholic steatohepatitis derived hepatocellular carcinoma
Involvement of a periodontal pathogen, Porphyromonas gingivalis on the pathogenesis of non-alcoholic fatty liver disease
"Endocrine NAFLD": a hormonocentric perspective of Non-Alcoholic Liver Disease (NAFLD) pathogenesis in HIV-infected patients
Epigenetic Markers and Microbiota/Metabolite-Induced Epigenetic Modifications in the Pathogenesis of Obesity, Metabolic Syndrome, Type 2 Diabetes, and Non-alcoholic Fatty Liver Disease
Epigenetic modifications in lymphoma: Relevance for pathogenesis and treatment
Bioprotective Role of Phytocompounds Against the Pathogenesis of Non-alcoholic Fatty Liver Disease to Non-alcoholic Steatohepatitis: Unravelling Underlying Molecular Mechanisms
Multiple organs involved in the pathogenesis of non-alcoholic fatty liver disease
The role of epigenetic modifications for the pathogenesis of Crohn's disease
Analysis of non-alcoholic beverages
Non-alcoholic fatty liver disease
Alcoholic and non-alcoholic steatohepatitis: global perspective and emerging science
The role of hepatic fat accumulation in pathogenesis of non-alcoholic fatty liver disease (NAFLD)
The influence of mTOR inhibition on the pathogenesis of non-alcoholic steatohepatitis derived hepatocellular carcinoma
Involvement of a periodontal pathogen, Porphyromonas gingivalis on the pathogenesis of non-alcoholic fatty liver disease
"Endocrine NAFLD": a hormonocentric perspective of Non-Alcoholic Liver Disease (NAFLD) pathogenesis in HIV-infected patients
Epigenetic Markers and Microbiota/Metabolite-Induced Epigenetic Modifications in the Pathogenesis of Obesity, Metabolic Syndrome, Type 2 Diabetes, and Non-alcoholic Fatty Liver Disease
Epigenetic modifications in lymphoma: Relevance for pathogenesis and treatment
Bioprotective Role of Phytocompounds Against the Pathogenesis of Non-alcoholic Fatty Liver Disease to Non-alcoholic Steatohepatitis: Unravelling Underlying Molecular Mechanisms
Multiple organs involved in the pathogenesis of non-alcoholic fatty liver disease
The role of epigenetic modifications for the pathogenesis of Crohn's disease
Analysis of non-alcoholic beverages
Non-alcoholic fatty liver disease
Alcoholic and non-alcoholic steatohepatitis: global perspective and emerging science
The role of hepatic fat accumulation in pathogenesis of non-alcoholic fatty liver disease (NAFLD)
The influence of mTOR inhibition on the pathogenesis of non-alcoholic steatohepatitis derived hepatocellular carcinoma
Involvement of a periodontal pathogen, Porphyromonas gingivalis on the pathogenesis of non-alcoholic fatty liver disease